EGFR and hepatocellular carcinoma: In addition, Zhan et al. found that PTPN13 was downregulated in HCC and inhibited epithelial–mesenchymal transition (EMT) through the inactivation of the EGFR/ERK signaling pathway, which suggested that PTPN13 is a tumor suppressor in HCC [23].